Equities

LeMaitre Vascular Inc

LeMaitre Vascular Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)107.97
  • Today's Change2.10 / 1.98%
  • Shares traded134.44k
  • 1 Year change+102.42%
  • Beta0.9110
Data delayed at least 15 minutes, as of Nov 22 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year LeMaitre Vascular Inc grew revenues 19.69% from 161.65m to 193.48m while net income improved 45.89% from 20.64m to 30.11m.
Gross margin68.34%
Net profit margin19.40%
Operating margin23.29%
Return on assets11.62%
Return on equity13.33%
Return on investment12.66%
More ▼

Cash flow in USDView more

In 2023, LeMaitre Vascular Inc increased its cash reserves by 26.84%, or 5.14m. The company earned 36.75m from its operations for a Cash Flow Margin of 18.99%. In addition the company used 24.72m on investing activities and also paid 7.13m in financing cash flows.
Cash flow per share2.25
Price/Cash flow per share46.72
Book value per share14.73
Tangible book value per share10.13
More ▼

Balance sheet in USDView more

LeMaitre Vascular Inc uses little or no debt in its capital structure.
Current ratio7.74
Quick ratio5.52
Total debt/total equity0.00
Total debt/total capital0.00
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 12.37% and 44.25%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg)0.94%
Div growth rate (5 year)15.51%
Payout ratio (TTM)33.63%
EPS growth(5 years)3.81
EPS (TTM) vs
TTM 1 year ago
49.62
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.